“Pathophysiology And Management Of Sickle Cell Disease: New Therapeutic Approaches And Disease-Modifying Treatments”, Journal of Pharmaceutical Negative Results, vol. 13, no. 4, pp. 2305–2310, Oct. 2022, doi: 10.47750/ceg2qf48.